SOUTH SAN FRANCISCO, Calif., June 16, 2018 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq:CYTK) today announced data from the Phase 2
Continue reading »
mypharmacynews.com
SOUTH SAN FRANCISCO, Calif., June 16, 2018 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq:CYTK) today announced data from the Phase 2
Continue reading »